Larvol Delta - CNS-Pharmaceuticals-Receives-Approval-from-Switzerland-Ethics-Committee-for-its-Potentially-Pivotal-Study-of-Berubicin-for-the-Treatment-of-Glioblastoma-Multiforme-GBM

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-receives-approval-from-switzerland-ethics-committee-for-its-potentially-pivotal-study-of-berubicin-for-the-treatment-of-glioblastoma-multiforme-gbm-301435822.html

Dec 2, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next